Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Shockwave Medical Stock Quote

Shockwave Medical (NASDAQ: SWAV)

$327.52
(0.0%)
$0.02
Price as of April 18, 2024, 4:00 p.m. ET

Shockwave Medical Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
SWAV +24.89% +987.38% +61.08% +974%
S&P +20.88% +72.88% +11.56% +82%

Shockwave Medical Company Info

Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.

News & Analysis

The Fool has written over 100 articles on Shockwave Medical.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.